Homocystinuria clinical trials

Explore recruiting homocystinuria clinical trials.

Recruiting homocystinuria studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Homocystinuria trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Parallel-group Treatment, Blinded, Randomized, Placebo-controlled Study to Assess the Efficacy and Safety of Pegtibatinase Administered Subcutaneously in Addition to Standard of Care in Participants with Classical Homocystinuria due to Cystathionine Beta Synthase Deficiency (HARMONY)

Belgium, Ireland, Spain, Italy, Germany, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 1/2 STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFECTS ON CLINICAL OUTCOMES OF PEGTIBATINASE (TVT-058) ADMINISTERED SUBCUTANEOUSLY IN SUBJECTS WITH CYSTATHIONINE BETASYNTHASE-DEFICIENT HOMOCYSTINURIA (COMPOSE)

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Homocystinuria trials by city

Homocystinuria in Toronto Homocystinuria in Vancouver Homocystinuria in Montreal Homocystinuria in Calgary Homocystinuria in Edmonton Homocystinuria in Ottawa Homocystinuria in Winnipeg Homocystinuria in Quebec City Homocystinuria in Hamilton Homocystinuria in Kitchener Homocystinuria in London Homocystinuria in Halifax Homocystinuria in New York Homocystinuria in Los Angeles Homocystinuria in Chicago Homocystinuria in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease